Noemi Reguart

4.2K posts

Noemi Reguart banner
Noemi Reguart

Noemi Reguart

@NReguart

MD, PhD, Lead Thoracic Oncol. Unit @hospitalclinic, MedOnc, Prof. @unibarcelona, Researcher Transl Genom 🧬 Targeted Therapies @IDIBAPS, @EORTC @GECP_org, #LCSM

Sitges, España Katılım Mart 2017
607 Takip Edilen3.5K Takipçiler
Noemi Reguart
Noemi Reguart@NReguart·
📢 A gentle reminder: nominations for the 2026 ESMO Society Awards are open @myESMO Colleagues across our community are doing exceptional work — let’s make sure their contributions are recognized. We truly value your participation! 🗓 Deadline: 10 May #ESMOMembers #Oncology
ESMO - Eur. Oncology@myESMO

📢 The 2026 ESMO Society Awards nominations are now open! #ESMOMembers can propose outstanding contributors to #oncology for the different awards. 🗓 Deadline: 10 May 2026 🔗 ow.ly/w9mm50YIGnl #ESMOAwards #W4O #CancerResearch

English
0
1
6
2.3K
Noemi Reguart retweetledi
Hidehito HORINOUCHI
Hidehito HORINOUCHI@HHorinouchi·
🔄#ASCO25 REVIEW🔁 ☑️#LCSM Rapid Oral, Mets 🔥Telisotuzumab adizutecan (ABBV-400; Temab-A, c-Met ADC) in #EGFR-m NSCLC 🎙️ Dr. David Sommerhalder 🎯ORR 63% 🎯Uniform efficacy irrespective of c-Met, L858R/ex19del, resistance muts @OncoAlert @ASCO @Larvol meetings.asco.org/2025-asco-annu…
Hidehito HORINOUCHI tweet mediaHidehito HORINOUCHI tweet mediaHidehito HORINOUCHI tweet mediaHidehito HORINOUCHI tweet media
Hidehito HORINOUCHI@HHorinouchi

🆕 #ASCO25 🆙 ☑️#LCSM Rapid Oral, Mets 🔥Telisotuzumab adizutecan (ABBV-400; Temab-A, c-Met ADC) in #EGFR-m NSCLC 🎙️ Dr. David Sommerhalder 🎯ORR 63% 🎯Uniform efficacy irrespective of c-Met, L858R/ex19del, resistance muts @OncoAlert @ASCO @Larvol meetings.asco.org/2025-asco-annu…

English
0
4
21
6.8K
Noemi Reguart retweetledi
Grupo Español de Cáncer de Pulmón
Grupo Español de Cáncer de Pulmón@gecp_org·
⭕Nace la revista científica del GECP 👉 Lung Cancer and Clinical Research Journal ➡️ Sin tasas de publicación ➡️ Abierta a artículos, revisiones y casos clínicos ➡️ Revisión por pares 🧑‍⚕️👩‍⚕️ Envía tu trabajo o participa como revisor. lccrjournal.com/es/
Grupo Español de Cáncer de Pulmón tweet media
Español
0
2
3
150
Noemi Reguart retweetledi
ESMO - Eur. Oncology
ESMO - Eur. Oncology@myESMO·
👉 Calling ESMO members! Have you downloaded the hot-off-the-press 3rd edition of Thoracic Tumours: Essentials for Clinicians? 🔗 ow.ly/8YaA50YNOru
GIF
English
0
4
13
1.9K
Noemi Reguart retweetledi
ESMO - Eur. Oncology
ESMO - Eur. Oncology@myESMO·
👉 Dr. Thanyanan Baisamut invites you to submit your abstract for ESMO Asia 2026 in Singapore (4–6 Dec). Regional science drives relevant, sustainable and impactful solutions for cancer care across Asia. 🗓 Deadline: 21 July 🔗 ow.ly/HWeN50YP4oI #ESMOAsia26 #esmomeetings
ESMO - Eur. Oncology tweet media
English
0
4
10
1.1K
Noemi Reguart retweetledi
Helena Linardou
Helena Linardou@ElinardouHelena·
Two inspiring days in Athens 🇬🇷 co-chairing the ESMO Advanced Course on early NSCLC with @peters_solange and @g_mountzios Outstanding faculty who stayed, debated, taught & mentored throughout 👏 Brilliant participants who challenged, engaged & inspired 💡 Amazing ESMO team who made everything seamless 🙏 Education and knowledge shared locally to create impact globally. Hope to be back again next year ✨ @MartinReck2 @HendriksLizza @finn_corinne @JordiRemon @PrelajArsela @NReguart Keith Kerr Anne-Marie Dingemans Jean Yannis Perentes @myESMO @HeSMO_X @Women4Oncology @fairlifelcc @EllokGr @elekapLC @oncodaily @OncBrothers
Helena Linardou tweet mediaHelena Linardou tweet mediaHelena Linardou tweet media
English
0
6
34
1.9K
Noemi Reguart retweetledi
Tactics
Tactics@tactics_md·
⏳ Recta final para formar parte del II Simposio de Actualización en SCLC 📅 13 de mayo | #Madrid Una oportunidad clave para poner al día el abordaje del #CáncerdePulmón de células pequeñas junto a expertos de referencia. Coordinación científica: Dr. @Tony_Calles  · Dr. @PazAresLab  · Dra. @NReguart  🔗 Asegura tu plaza antes de cierre de inscripciones tacticsmd.net/actividad/ii-s…
Tactics tweet media
Español
0
3
5
306
Noemi Reguart retweetledi
Hidehito HORINOUCHI
Hidehito HORINOUCHI@HHorinouchi·
🆙 #ASCO26 #LCSM Oral Abstract Session 🔥ABBV-706 as Monotherapy and in Combination with Budigalimab in R/R SCLC 🎙️ @LaurenByersMD 🔢8008 ☑️NCT05599984 🔗 asco.org/abstracts-pres… @OncoAlert @Larvol @ASCO
Hidehito HORINOUCHI tweet media
Hidehito HORINOUCHI@HHorinouchi

☑️#WCLC25 #LCSM Oral Abstract🆙 🔥ABBV-706 (SEZ6-ADC) 🔥Safety and Efficacy of ABBV-706, a Seizure-related Homolog Protein 6-targeting Antibody-drug Conjugate, in R/R SCLC 🎯ORR 57.5% (46/80) 🎙️ @LaurenByersMD @OncoAlert @Larvol @IASLC cattendee.abstractsonline.com/meeting/21151/…

English
1
4
10
3.3K
Noemi Reguart
Noemi Reguart@NReguart·
Together with @EnriquetaFelip we are delighted to host this year’s Meet the Professor in Thoracic Tumors with Dr. Solange Peters @peters_solange: insight and inspiration at its best. Save the date!
Tactics@tactics_md

📣 Save the date Nueva edición de VII Meet with the Professor in Thoracic Tumors 2026 📅 22 de septiembre 💻 Virtual Un encuentro consolidado para compartir conocimiento y avanzar en el abordaje de los tumores torácicos junto a referentes del área. Coordinación científica: Dra. @EnriquetaFelip · Dra. @@NReguart Próximamente más información #ThoracicTumors #Oncología #SaveTheDate

English
0
0
3
176
Noemi Reguart retweetledi
Stephen V Liu, MD
Stephen V Liu, MD@StephenVLiu·
Phase II DRAGON study of deulorlatinib (TGRX-326) in ALK NSCLC post 2nd gen TKI @JTOonline. RR 43.7%, PFS 11.1m, intracranial RR 55.8%. In G1202R+, RR 62.5%, PFS 11m. CNS TRAE rate 12.9%. Only 0.6% of pts discontinued therapy due to TRAE (11% reduction). jto.org/article/S1556-…
English
1
11
32
2.1K
Noemi Reguart retweetledi
Giannis Mountzios
Giannis Mountzios@g_mountzios·
An exciting morning session here in @myESMO advanced course in early stage #NSCLC with a “deep dive” into : ➡️ Environmental Carcinogenesis ➡️screening ➡️ molecular pathology and MRD/ctDNA ➡️Defining Resectability ➡️Presurgical assessment post-chemoIO ➡️RT and AI applications ➡️Periop strategies in both AGA/ non-AGA
Giannis Mountzios tweet mediaGiannis Mountzios tweet mediaGiannis Mountzios tweet mediaGiannis Mountzios tweet media
English
2
4
21
811
Noemi Reguart retweetledi
Stephen V Liu, MD
Stephen V Liu, MD@StephenVLiu·
#AACR26 In CheckMate 77T, ctDNA clearance much more likely with perioperative nivolumab (75% vs 46%) and clearance with nivo more strongly associated with pCR (70%) than placebo (18%). Those who do not clear ctDNA have virtually no chance for pCR. Escalation strategy here?
Stephen V Liu, MD tweet media
English
1
19
46
7.5K
Noemi Reguart retweetledi
IASLC
IASLC@IASLC·
Final results from the ETOP ADEPPT trial, presented by Dr. @DrJNaidoo at #ELCC26, show promise for fit, elderly patients and those with poor PS. More details in ILCN: bit.ly/3QeItXI
English
0
4
27
3.1K
Noemi Reguart retweetledi
Stephen V Liu, MD
Stephen V Liu, MD@StephenVLiu·
Dr. @riess_md at #AACR26 updates RMC-9805 (zoldonrasib) in KRAS G12D NSCLC. Very impressive. G12D is a particular need in lung cancer as many patients have no smoking history and do not fare as well with immunotherapy. Zoldonrasib is a mutant selective, RAS(ON) inhibitor.
Stephen V Liu, MD tweet mediaStephen V Liu, MD tweet mediaStephen V Liu, MD tweet mediaStephen V Liu, MD tweet media
English
7
54
143
23.7K
Noemi Reguart retweetledi
Stephen V Liu, MD
Stephen V Liu, MD@StephenVLiu·
Phase I study of sigvotatug vedotin, an integrin beta-6 targeted ADC with an MMAE payload & a protease-cleavable linker, @JCO_ASCO. In 117 pts with NSCLC, RR 19%, DOR 11.3m and in pts with non-squamous, taxane naive NSCLC, RR 29%, DOR 12.8m. ascopubs.org/doi/10.1200/JC…
English
0
4
18
4.6K
Noemi Reguart retweetledi
Jordi Remon
Jordi Remon@JordiRemon·
Great discussions at the EORTC Lung Cancer Group meeting in Gdańsk. A real privilege to work with such a collaborative and forward-thinking community—especially encouraging to see new voices actively contributing to study design and research priorities. You are welcome!! #EORTC
Jordi Remon tweet mediaJordi Remon tweet mediaJordi Remon tweet media
English
0
15
54
2K
Noemi Reguart retweetledi
Giannis Mountzios
Giannis Mountzios@g_mountzios·
Farewell to another productive and exceptionally brainstorming @EORTC LCG meeting under the leadership and guidance of @JordiRemon @HendriksLizza @MarianaBrandao0 Huge 🙏 to Rafal Dziadziusco for a wonder honestly n beautiful Gdansk!! See you all next year in Athens!!!!
Giannis Mountzios tweet mediaGiannis Mountzios tweet mediaGiannis Mountzios tweet mediaGiannis Mountzios tweet media
English
0
5
20
705

Keşfet

@myESMO @OncoAlert @ASCO @Larvol @GuiNaderMarta @MaximilianKloft @mihaela_aldea @rdienstmann